Target intelligence / Profile preview

Cysteine and histidine rich domain containing 1 (CHORDC1)

Target
CHORDC1
Molecular classification
Co-chaperone, Other (zinc-binding protein), Protein binding regulator
01

Overview

Cysteine and histidine rich domain containing 1 (CHORDC1) is a zinc-binding co-chaperone protein that interacts with the molecular chaperone Hsp90 and possibly other partners, regulating key processes such as centrosome duplication, chaperone-mediated protein folding, Rho-dependent kinase activity, and particularly the maturation and trafficking of the epidermal growth factor receptor (EGFR). CHORDC1 ensures correct EGFR localization to the plasma membrane, thereby affecting downstream MAPK signaling, cell proliferation, and cytoskeletal organization. Its role is essential for cellular viability, and dysregulation contributes to impaired EGFR signaling, cytoskeletal abnormalities, and can modulate cancer susceptibility and progression. Drugs affecting chaperone activities, like geldanamycin, further highlight the therapeutic relevance of CHORDC1 in cancer and cell biology. CHORDC1 is broadly expressed across human tissues and has several conserved homologs and aliases.

Other names
CHORDC1CHP1CHP-1CHORD domain-containing protein 1Protein morganaMorganaCysteine and histidine-rich domain-containing protein 1CHORD-containing protein 1
02

Mechanism of action

Geldanamycin: Hsp90 inhibition decreases EGFR stability, especially in CHORDC1-deficient cells. Potential modulation of chaperone-mediated signaling pathways.

03

Biological functions

Chaperone-mediated protein foldingHsp90 protein bindingRegulation of centrosome duplicationNegative regulation of Rho-dependent serine/threonine kinase activityRegulation of EGFR traffickingStress responseCell proliferation and actin cytoskeleton remodeling
04

Disease associations

Cancer (prevents tumorigenesis, regulates EGFR maturation, involved in NF-kappaB signaling in breast cancer cells)Inclusion conjunctivitis
05

Safety considerations

Broad inhibition (e.g., co-chaperones) may affect many proteins, potentially leading to off-target toxicityCell lethality observed in knockout models, suggesting essential cellular role
06

Interacting drugs

Geldanamycin (Hsp90 inhibitor)
07

Biomarkers

CHORDC1 expression level (possible for EGFR-related signaling and tumorigenesis)EGFR localization/stability and MAPK activity could serve as functional readouts

Beyond the preview

Go deeper on Cysteine and histidine rich domain containing 1 (CHORDC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysteine and histidine rich domain containing 1 (CHORDC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call